| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -30.6% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 7.0 | n/a |
| Pr/Book | 15.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 43.8% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 87.73 | (6.57) | (7.81)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 142.80 | 19.88 | 22.77p | 54.0 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 139.99 | (45.98) | (41.29)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 89.54 | (188.53) | (163.11)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 128.80 | (47.26) | (41.75)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| Block Listing Return | 02-Jan-2026 | 07:00 | RNS |
| Block Listing Return | 02-Jan-2026 | 07:00 | RNS |
| Total Voting Rights | 02-Jan-2026 | ShareCast |
| Block Listing Return | 02-Jan-2026 | ShareCast |
| Oxford Biomedica acquires US viral vector facility | 07-Oct-2025 | ShareCast |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 749.00p |
| Change Today | 19.00p |
| % Change | 2.60 % |
| 52 Week High | 764.00p |
| 52 Week Low | 232.50p |
| Volume | 365,163 |
| Shares Issued | 120.75m |
| Market Cap | £904.44m |
| Beta | 1.75 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:47 | 2,364 @ 734.86p |
| 16:35 | 25,000 @ 749.00p |
| 16:35 | 44,771 @ 749.00p |
| 16:35 | 8 @ 749.00p |
| 16:35 | 117 @ 749.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research